Regeneron

If you’ve been following along over the past week, you’ve seen how thousands of our colleagues worldwide dedicated their time and energy to giving back to local communities during our eighth annual #RegeneronD4DG.  We’re proud of how our teams contributed to creating healthier, more equitable communities during this global week of service: 👥 ~7,000 Regeneron volunteers – more than half of our global workforce! 🌎 13 participating countries 🤝 450+ community service projects 🏘️ 250 community organizations supported around the world Learn more about our community impact: https://bit.ly/3Aq2Lpu

Science Magazine has named us the #2 top employer among biotech, pharma and biopharma industries. At Regeneron, whether we’re in the lab, at a desk, in a manufacturing facility, or out in the field, we share a unified mission: use the power of science to bring new medicines to patients. What sets us apart? Our mission resonates deeply and personally with each of us. Hear from our dedicated team about our commitment to innovation, wellbeing and social responsibility. https://bit.ly/3UKOHOD #SCTopEmployers

That’s a wrap on this year’s Hispanic Heritage Month celebration organized by our Juntos employee resource group (ERG), which works to enrich the Hispanic and LatinX community at Regeneron and beyond. Events ranged from pure fun and connection, like a Cuban salsa dance workshop and “Sabor Latino” cooking class, to scientific, like a keynote address by pioneering scientist Dr. Fernando Camargo and a Health Equity Seminar focused on health disparities among Hispanic/LatinX patients. Learn more about how our ERGs contribute to our culture of inclusion, helping to create an exceptional workplace and supporting under-served communities: https://bit.ly/4dUbeyZ

Today we're presenting our latest research on our investigational gene therapy for otoferlin-related hearing loss at the European Society of Gene and Cell Therapy Congress.    Learn more about our approach to advancing gene therapy research in the hopes of addressing underlying causes of genetic hearing loss: https://bit.ly/3zHLp7g

By harnessing the potential of genetic research, we aim to create new therapeutic approaches that could provide solutions for conditions that need more.    Learn more about our approach to genetics research: https://bit.ly/4eNYTOb

Today marks the one-year anniversary of Together for CHANGE™ and our commitment to STEM education in Nashville. To improve health outcomes and increase representation in STEM careers for people of African ancestry, we supported the launch of the Diaspora Human Genomics Institute (DHGI), as well as the establishment of its governance and operational processes, and assisted DHGI in the development of relationships with potential collaborators around the world.    We also actively supported the STEM ecosystem in the Nashville metropolitan area by partnering with eight STEM-education-focused nonprofits. Through these collaborations, we’ve provided students with hands-on research experiences, offered professional development opportunities for educators, and fostered the growth of the Middle Tennessee Science and Engineering Fair.     We thank the DHGI, and consortium members Meharry Medical College, AstraZeneca, Novo Nordisk and Roche for their continued collaboration. Discover more about this important initiative: https://bit.ly/47W5kMx

Doing Well by Doing Good is an ethos we champion every day — but especially today as we kick off our eighth annual Day for Doing Good! Hear from the people who make this global service event possible: our dedicated and enthusiastic colleagues. Discover what drives them to extend our mission of improving lives beyond our everyday work. #RegeneronD4DG

When it comes to corporate responsibility, we give it our everything and then we give more. Guided by our philosophy of "Doing Well by Doing Good," we apply our science-first, high-integrity culture to shape a brighter tomorrow — to improve lives, uplift the next generation of scientific innovators, and build sustainable communities. Learn more about our impact: https://bit.ly/4eIuOj1

We’re ready to make a difference! Next Friday kicks off our 8th annual Day for Doing Good (#RegeneronD4DG) — a week of global volunteerism that showcases the power of our team’s diverse talents, time and leadership to strengthen and support our local communities. Hear our colleagues around the world share their experiences with D4DG and get ready to be inspired by the over 350 projects we’re supporting this year. Stay tuned as we kick off an exciting week of giving back!

Join us in congratulating Aris Baras, SVP, Head of Regeneron Genetics Center and co-Head of Regeneron Genetic Medicines, on being named a PharmaVoice 100 honoree. His vision helps shape the future of genetics research at Regeneron and beyond, paving the way for innovative new treatments.    To hear more from him and other industry leaders, visit: https://bit.ly/4eTwAh0